Discussion of tumor mutation burden as an indicator to predict efficacy of immune checkpoint inhibitors: A case report

Discussion of tumor mutation burden as an indicator to predict efficacy of immune checkpoint inhibitors: A case report: There are many treatment options for advanced lung cancer, among which immunotherapy has developed rapidly and #oncology… https://t.co/

New research: Discussion of tumor mutation burden as an indicator to predict efficacy of immune checkpoint inhibitors: A case report: There are many treatment options for advanced lung cancer, among which immunotherapy has developed rapidly and… https://t.